SG Americas Securities
KYMR icon

SG Americas Securities’s Kymera Therapeutics KYMR Stock Holding History

SG Americas Securities’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$536K Buy
4,674
+1,511
+48% +$130K ﹤0.01% 2284
2026
Q1 		$263K Sell
3,163
-19,530
-86% -$1.55M ﹤0.01% 2514
2025
Q4 		$1.77M Buy
22,693
+14,261
+169% +$963K ﹤0.01% 1609
2025
Q3 		$477K Sell
8,432
-13,633
-62% -$615K ﹤0.01% 2160
2025
Q2 		$963K Buy
+22,065
New +$760K ﹤0.01% 1204
2025
Q1 		– Sell
-8,025
Closed -$323K – 3614
2024
Q4 		$323K Sell
8,025
-6,694
-45% -$302K ﹤0.01% 1726
2024
Q3 		$697K Buy
14,719
+3,832
+35% +$169K ﹤0.01% 1393
2024
Q2 		$325K Buy
10,887
+6,934
+175% +$240K ﹤0.01% 1917
2024
Q1 		$159K Sell
3,953
-14,610
-79% -$523K ﹤0.01% 2153
2023
Q4 		$473K Buy
+18,563
New +$332K ﹤0.01% 1515
2023
Q2 		– Sell
-8,772
Closed -$260K – 2750
2023
Q1 		$260K Buy
+8,772
New +$283K ﹤0.01% 2219
2022
Q4 		– Sell
-8,629
Closed -$188K – 3225
2022
Q3 		$188K Sell
8,629
-28,716
-77% -$757K ﹤0.01% 2378
2022
Q2 		$735K Buy
37,345
+30,301
+430% +$708K 0.01% 1599
2022
Q1 		$298K Sell
7,044
-3,532
-33% -$149K ﹤0.01% 2196
2021
Q4 		$671K Sell
10,576
-6,327
-37% -$369K ﹤0.01% 1943
2021
Q3 		$993K Buy
16,903
+13,381
+380% +$776K ﹤0.01% 1913
2021
Q2 		$171K Sell
3,522
-488
-12% -$21.2K ﹤0.01% 2411
2021
Q1 		$156K Buy
+4,010
New +$241K ﹤0.01% 2835

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SG Americas Securities's KYMR Position: Q2 2026 in Review

SG Americas Securities increased its Kymera Therapeutics (KYMR) stake by 48% in Q2 2026, buying an estimated $130K and bringing the position to 4,674 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #2284.

SG Americas Securities first reported a position in KYMR in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.77M in Q4 2025. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • SG Americas Securities held 4,674 shares of Kymera Therapeutics worth $536K as of Q2 2026.
  • SG Americas Securities bought 1,511 Kymera Therapeutics shares in Q2 2026, an estimated $130K.
  • Kymera Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2284 holding.
  • SG Americas Securities first reported a position in Kymera Therapeutics in Q1 2021 and has held it in 18 quarters since.
  • SG Americas Securities's Kymera Therapeutics position peaked at $1.77M in Q4 2025.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.